Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
Market Capitalization: 432.92 M
The data is delayed by 15 minutes.
Description: Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors in Europe, Japan and rest of Asia, South America, and internationally to hospitals and stand-alone treatment facilit
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||80.92 M||EPS||-0.38||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-4.4%||Sales Growth - Q/Q||-0.65%||P/E||-11.45|
|P/E To EPS Growth||P/S||1.14||P/BV||5.66||Price/Cash Per Share||2.84|
|Price/Free Cash Flow||-37.37||ROA||-9.58%||ROE||-58.08%||ROI||-15.43%|
|Current Ratio||2.1||Quick Ratio||1.44||Long Term Debt/Equity||1.1||Debt Ratio||2.17|
|Gross Margin||37.73%||Operating Margin||-5.88%||Net Profit Margin||-11.69%||Dividend Payout Ratio|
|Cash From Financing Activities||4.71 M||Cash From Investing Activities||18.63 M||Cash From Operating Activities||-12.6 M||Gross Profit||38.66 M|
|Net Profit||-2.97 M||Operating Profit||1.17 M||Total Assets||463.66 M||Total Current Assets||347.97 M|
|Total Current Liabilities||165.79 M||Total Debt||200.99 M||Total Liabilities||387.18 M||Total Revenue||97.52 M|
|High 52 week||5.28||Low 52 week||3.31||Last close||3.91||Last change||-0.26%|
|RSI||29.63||Average true range||0.16||Beta||1.14||Volume||646.59 K|
|Simple moving average 20 days||-6.19%||Simple moving average 50 days||-11.09%||Simple moving average 200 days||-7.16%|
|Performance Week||-5.56%||Performance Month||-2.49%||Performance Quart||-20.69%||Performance Half||-17.86%|
|Performance Year||-17.68%||Performance Year-to-date||14.66%||Volatility daily||2.61%||Volatility weekly||5.83%|
|Volatility monthly||11.95%||Volatility yearly||41.39%||Relative Volume||806.1%||Average Volume||790.74 K|
|New High||New Low||-1.08%|
2019-08-23 18:48:05 | Accuray Inc ARAY Files 10-K for the Fiscal Year Ended on June 30, 2019
2019-08-21 07:30:00 | Froedtert & the Medical College of Wisconsin Cancer Network is First in the World to Treat Cancer Patient Using the Accuray Radixact® System with Synchrony® Motion Tracking and Correction Technology
2019-08-16 12:33:00 | Here's Why Accuray Stock Is Nosediving Today
2019-08-16 09:47:01 | Accuray ARAY Reports Loss in Q4, Revenues Beat Estimates
2019-08-16 06:00:00 | No Hooray for Accuray in Q4
2019-08-16 01:41:28 | Edited Transcript of ARAY earnings conference call or presentation 15-Aug-19 8:30pm GMT
2019-08-15 21:23:24 | Accuray Inc ARAY Q4 2019 Earnings Call Transcript
2019-08-15 17:25:09 | Accuray ARAY Reports Q4 Loss, Tops Revenue Estimates
2019-08-15 16:05:00 | Accuray Reports Fourth Quarter and Fiscal 2019 Financial Results
2019-08-15 07:33:31 | Earnings Outlook For Accuray
2019-08-14 13:10:01 | Does Accuray Incorporated's NASDAQ:ARAY CEO Salary Compare Well With Others?
2019-08-08 10:30:02 | Accuray ARAY Earnings Expected to Grow: What to Know Ahead of Next Week's Release
2019-07-23 07:30:00 | Accuray Provides Update on China Joint Venture Operational Progress
2019-06-23 20:55:10 | Is Accuray Incorporated ARAY A Good Stock To Buy?
2019-06-12 15:10:10 | How Many Accuray Incorporated NASDAQ:ARAY Shares Do Institutions Own?
2019-06-05 10:05:02 | AngioDynamics Divests NAMIC Portfolio to Medline Industries
2019-05-07 15:31:33 | Volatility 101: Should Accuray NASDAQ:ARAY Shares Have Dropped 47%?
2019-05-01 10:00:02 | Varian's VAR Halcyon to Treat Patients at Japan's Hospital
2019-04-24 18:08:44 | Edited Transcript of ARAY earnings conference call or presentation 23-Apr-19 8:30pm GMT
2019-04-24 10:40:02 | Accuray ARAY Q3 Earnings Top Estimates, Gross Orders Rise
2019-04-23 21:49:45 | Accuray Inc ARAY Q3 2019 Earnings Call Transcript
2019-04-23 18:15:10 | Accuray ARAY Reports Q3 Loss, Misses Revenue Estimates
2019-04-23 17:09:11 | Accuray: Fiscal 3Q Earnings Snapshot
2019-04-23 16:05:00 | Accuray Reports Fiscal 2019 Third Quarter Results
2019-04-23 14:30:00 | Accuray Incorporated to Host Earnings Call
2019-04-16 10:31:02 | Accuray ARAY May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2019-04-11 08:33:12 | Here's Why Investors Should Retain Accuray ARAY Stock Now
2019-04-09 09:41:01 | Varian Medical's VAR ProBeam Installed in China's HIMC
2019-04-07 09:16:00 | Better Buy: Intuitive Surgical vs. Accuray
2019-04-04 15:42:03 | When Can We Expect A Profit From Accuray Incorporated NASDAQ:ARAY?
2019-04-02 07:30:00 | Accuray to Report Fiscal 2019 Third Quarter Financial Results on April 23, 2019
2019-03-27 08:34:12 | Varian Medical VAR Collaborates With Korea-Based Hospital
2019-03-18 08:58:12 | Intuitive Surgical da Vinci SP Gets FDA Nod, Prospects Bright
2019-03-12 08:48:12 | Varian & Tata Trust Tie Up to Boost Radiotherapy in India
2019-02-21 09:30:02 | Why Is Accuray ARAY Up 17% Since Last Earnings Report?
2019-02-20 16:06:00 | Cutera Appoints Katherine Zanotti and Joseph Whitters to its Board of Directors
2019-02-12 09:48:02 | Here's Why Investors Should Retain Accuray ARAY Stock Now
2019-02-06 10:33:15 | When Should You Buy Accuray Incorporated NASDAQ:ARAY?
2019-02-01 08:00:00 | Factors of Influence in 2019, Key Indicators and Opportunity within Marathon Oil, Accuray, United Natural Foods, Systemax, Amgen, and NewLink Genetics — New Research Emphasizes Economic Growth
2019-01-30 09:02:02 | Varian Strong on Global Expansion and Proton Therapy Arm
2019-01-29 10:32:03 | Accuray & China Isotope Collaborate to Sell Radiation Devices
2019-01-28 06:18:56 | BRIEF-Accuray And China Isotope And Radiation Corp Enter Joint Venture Contract